Malavasi, Vincenzo L.
Vitolo, Marco
Colella, Jacopo
Montagnolo, Francesca
Mantovani, Marta
Proietti, Marco
Potpara, Tatjana S.
Lip, Gregory Y. H.
Boriani, Giuseppe http://orcid.org/0000-0002-9820-4815
Article History
Received: 1 September 2021
Accepted: 7 November 2021
First Online: 2 December 2021
Declarations
:
: TP is a consultant for Bayer and Pfizer (no fees). GB has received small speaker’s fees from Medtronic, Boston, Boehringer Ingelheim, and Bayer. GYHL is a consultant and speaker for Bayer/Janssen, BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo (no fees are directly received personally). All the disclosures happened outside the submitted work. Other authors have no disclosures to declare.
: This prospective observational study was approved by the Local Ethical Committee for Medical Research in compliance with the ethical standards of the institutional and national regulations. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All patients gave written informed consent for participation.